« Return to News | Awards & Advancement

Paul Fonteyne named president, CEO of Boehringer Ingelheim USA

Friday, February 10, 2012 11:42 AM

Paul R. Fonteyne has been promoted to U.S. country managing director and president and CEO of Boehringer Ingelheim USA. Fonteyne assumes this role from J. Martin Carroll, who remains with the company in a corporate strategy and development role and a member of the board.

Fonteyne previously was corporate senior vice president for Boehringer Ingelheim USA, responsible for leading the global marketing strategy supporting the company’s prescription medicines business. In this role, he helped drive growth in the company's core areas of respiratory and cardiovascular disease, as well as positioned it to enter new areas of diabetes and oncology.

"I have worked with Paul for more than 15 years, and am confident that his depth and breadth of experience, combined with his passion for finding new ways to bring medicines to patients makes him well suited to take on this role and help lead the company to even greater success,” said Carroll.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.